Y10S 930/32
Modification to prevent enzymatic degradation
Y10S930/32 (Modification to prevent enzymatic degradation) appears on 12 US grants and 3 published applications in this corpus.
Search patents in Y10S- Granted patents
- 12
- Published applications
- 3
- Assignees
- 10
- Inventors
- 23
- Latest grant
- 18 Mar 2014
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 1 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Polypeptoid pulmonary surfactants18 Mar 2014US 8,673,842 B2Chiron Corporation
- Polypeptoid pulmonary surfactants14 Feb 2012US 8,114,830 B2Chiron Corporation
- Polypeptoid pulmonary surfactants3 May 2005US 6,887,845 B2Chiron Corporation
- Mimetic insect kinin analogs for insect control11 Aug 1998US 5,792,466 AThe United States of America as represented by the Secretary of Agriculture
- Pentapeptide having specific inhibiting effect on epidermal cell proliferation, the salts thereof, pharmaceutical compositions comprising the same and a process for the preparation of the pentapeptide and the pharmaceutical compositions12 Oct 1993US 5,252,558 ARichter Gedeon Vegyeszeti Gyar Rt.
Most cited
By later US patents
- Active site modified protease .alpha.-1-antitrypsin inhibitors41US 4,732,973 AChiron Corporation · 1988
- LHRH antagonists30US 5,171,835 AThe Administrators of the Tulane Educational Fund · 1992
- Polypeptoid pulmonary surfactants22US 6,887,845 B2Chiron Corporation · 2005
- GRF analogs II20US 4,626,523 AThe Salk Institute for Biological Studies · 1986
- GRF analogs IIIb19US 4,728,726 AThe Salk Institute for Biological Studies · 1988